"Formycon and Bioeq Report the US FDA’s Acceptance of BLA for FYB201 (biosimilar, ranibizumab) @Pharmashot @formycon https://t.co/jog3jojTww"

FYB201 (ranibizumab biosimilar) - Amneal, Formycon, Coherus Biosci, Teva

Oct 4, 2021